Mutations, Hormone Therapy (HRT) and Venous Thromboembolism
NCT00005515 · Status: COMPLETED · Type: OBSERVATIONAL
Last updated 2016-02-10
Summary
To assess the interaction between hormone replacement therapy and the prothrombotic mutations, Factor V Leiden and the recently described prothrombin mutation (20210A) on the incidence of venous thromboembolism (VTE) in a population-based case-control study conducted at Group Health Cooperative of Puget Sound (GHC).
Conditions
- Cardiovascular Diseases
- Venous Thromboembolism
- Postmenopause
Sponsors & Collaborators
-
National Heart, Lung, and Blood Institute (NHLBI)
collaborator NIH - lead OTHER
Principal Investigators
-
Bruce Psaty · University of Washington
Eligibility
- Min Age
- 30 Years
- Max Age
- 89 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1998-09-30
- Completion
- 2003-08-31
More Related Trials
-
Risk Factors of Venous Thromboembolism in Women During Hormonal Exposure
NCT03206372 ·Status: RECRUITING
-
Epidemiology of Venous Thromboembolism
NCT00041457 ·Status: COMPLETED
-
Antithrombin to Improve Thromboprophylaxis and Reduce the Incidence of Trauma-Related Venous Thromboembolism
NCT05794165 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE2
-
Venous Thromboembolism in Hematologic Malignancy and Hematopoietic Cell Transplant Patients: a Retrospective Study
NCT05396157 ·Status: ACTIVE_NOT_RECRUITING
-
Prevalence of Gynecological Pathologies and Use of Hormonal Treatments in Women Hospitalized for a Venous Thromboembolic Episode
NCT04920487 ·Status: COMPLETED
-
Evaluation of a Preventive Therapeutic Strategy for Postpartum Venous Thromboembolism in Women With Genetic Risk Factor
NCT07342127 ·Status: COMPLETED
-
Systematic Review and Meta-Analysis of Venous Thromboembolism (VTE) Risk Assessment in Hospitalized Medical Patients
NCT01446510 ·Status: WITHDRAWN
-
Predicting Bleeding Risk on Anticoagulant Therapy for Venous Thromboembolism
NCT00788736 ·Status: COMPLETED
-
Medical Assistance for the Procreation and Risk of Thrombosis.
NCT02610608 ·Status: TERMINATED
-
Treatment Patterns Among Patients With Venous Thromboembolism in the United States
NCT05795062 ·Status: COMPLETED
-
Assess Incidence of Deep Vein Thrombosis(DVT)Following Administration of Recombinant Human Antithrombin (rhAT) to Hereditary Antithrombin(AT) Deficient Patients in High Risk Situations.
NCT00056550 ·Status: COMPLETED ·Phase: PHASE3
-
New Genetic Mutations in Thromboembolic Venous Disease Idiopathic. Study "FIT GENETIQUE".
NCT02841085 ·Status: COMPLETED
-
Genetics Informatics Trial (GIFT) of Warfarin to Prevent DVT
NCT01006733 ·Status: COMPLETED ·Phase: PHASE3
-
Risk, Predictors, Impact and Outcome of Anticoagulation-associated Abnormal Menstrual Bleeding
NCT04748393 ·Status: TERMINATED
-
inDividual, Targeted thrombosIS Prophylaxis Versus the Standard 'One Size Fits All' Approach in Patients Undergoing Total hIp or Total kNee replaCemenT
NCT06581965 ·Status: RECRUITING ·Phase: PHASE4
-
A Study to Compare the Risk of a Major Bleeding in Participants Who Received Blood Thinning Medications Following a Blood Clot
NCT03521908 ·Status: COMPLETED
-
Need for Antepartum Thromboprophylaxis in Pregnant Women With One Prior Episode of Venous Thromboembolism (VTE)
NCT01357941 ·Status: UNKNOWN
-
Prospective Genotyping For Total Hip or Knee Replacement Patients Receiving Warfarin (Coumadin)
NCT00634907 ·Status: COMPLETED ·Phase: NA
-
Evaluation of an Antithrombotic Therapeutic Strategy in Pregnant Women
NCT00745212 ·Status: COMPLETED
-
Comparison of Warfarin Dosing Using Decision Model Versus Pharmacogenetic Algorithm
NCT00511173 ·Status: COMPLETED ·Phase: PHASE4
-
Long-term Surveillance of Patients With Venous Thromboembolism: a Nationwide Prospective Cohort Study
NCT06073366 ·Status: COMPLETED
-
Efficacy and Safety of Low-molecular Weight Heparin for Thromboprophylaxis in Acutely Ill Medical Patients
NCT00311753 ·Status: COMPLETED ·Phase: PHASE3
-
A Comparison of Extended Versus Conventional Duration of Enoxaparin Prophylaxis (i.e., Preventive Treatment) for Venous Thromboembolism (VTE, i.e., Blood Clots in the Veins) and Bleeding Event Risk in a Population With Acute Medical Illness
NCT05819112 ·Status: TERMINATED
-
Best Antithrombotic Therapy in Patients With Acute Venous ThromboEmbolism While Taking Antiplatelets
NCT05627375 ·Status: RECRUITING ·Phase: PHASE3
-
Efficacy of Aspirin in Preventing Venous Thromboembolism
NCT06635317 ·Status: COMPLETED ·Phase: PHASE4